Circulating dipeptidyl peptidase (cDPP3)—A marker for end‐stage heart failure?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating dipeptidyl peptidase (cDPP3)—A marker for end‐stage heart failure?

Published:2022-01-10 Issue:6 Volume:291 Page:886-890
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Pavo Noemi¹^ORCID,Prausmüller Suriya¹,Spinka Georg¹,Goliasch Georg¹,Bartko Philipp E¹,Arfsten Henrike¹,Santos Karine²,Strunk Guido³,Hülsmann Martin¹

Affiliation:

1. Department of Internal Medicine II Clinical Division of Cardiology Medical University of Vienna Vienna Austria

2. 4TEEN4 Pharmaceuticals GmbH Hennigsdorf Germany

3. Complexity Research Vienna, Austria; FH Campus Vienna, Vienna, Austria and Technical University Dortmund Dortmund Germany

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13449

Reference5 articles.

1. Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics

2. Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial

3. Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure

4. Serum neprilysin and the risk of death in patients with out-of-hospital cardiac arrest of non-traumatic origin

5. Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of an Additional Metal-Binding Site in Human Dipeptidyl Peptidase III;International Journal of Molecular Sciences;2023-08-13

2. DPP3: From biomarker to therapeutic target of cardiovascular diseases;Frontiers in Cardiovascular Medicine;2022-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3